Xin Qiu

Peking University

H指数:17

被引数:946

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Novel and recurrent TUBB8 variants cause irreversible meiotic spindle defects and refractory ART failure in Chinese women with oocyte maturation arrest

新型和复发性TUBB8变异导致中国卵母细胞成熟阻滞女性患者出现不可逆的减数分裂纺锤体缺陷和难治性辅助生殖技术失败

Journal of Assisted Reproduction and Genetics

IF2.7

2026-09-180

PRE

Novel biallelic PATL2 variants causing predominant germinal vesicle arrest and recurrent ART failure: expanded mutational spectrum and evidence-based reproductive counseling guidance

新型双等位基因PATL2变异导致主要卵母细胞生发泡阻滞和反复辅助生殖技术失败：扩展的突变谱及循证生殖咨询指导

Journal of Assisted Reproduction and Genetics

IF2.7

2026-08-260

PRE

TEX43, a testis-enriched microtubule-associated gene, exerts minimal impact on spermatogenesis and fertility in mice and humans

TEX43，一种睾丸富集的微管相关基因，对小鼠和人类的精子发生及生育能力影响极小

Journal of Assisted Reproduction and Genetics

IF2.7

2026-05-230

PRE

TEX29 is a novel acrosome marker dispensable for spermatogenesis and fertilization in mice

TEX29是小鼠精子发生和受精过程中一种新型顶体标志物，但对精子发生和受精并非必需

Journal of Assisted Reproduction and Genetics

IF2.7

2026-05-230

PRE

TEX44 deficiency induces asthenoteratozoospermia by disrupting sperm axonemal integrity and mitochondrial sheath assembly, and ICSI enables successful fertility rescue

TEX44缺乏通过破坏精子轴丝完整性和线粒体鞘组装诱导弱畸精子症，而ICSI能够实现成功的生育挽救

Journal of Assisted Reproduction and Genetics

IF2.7

2026-05-140

PRE

Platelet CLEC-2 activation leads to GPIb⍺ shedding: implications for doxorubicin chemotherapy and thrombosis

血小板CLEC-2活化导致GPIbα脱落：对多柔比星化疗和血栓形成的意义

Journal of Biological Chemistry

IF3.9

2026-04-270

OAAI

Chromatin deactivation in pre-granulosa cells contributes to primordial follicle formation

卵泡膜细胞前体的染色质失活有助于原始卵泡的形成。

Journal of Biological Chemistry

IF3.9

2025-08-140

PREAI

Nadir testosterone levels following androgen deprivation therapy (ADT) and outcomes in Chinese patients with metastatic prostate cancer (mPC): The PROTECH study

接受雄激素剥夺疗法（ADT）后中国转移性前列腺癌（mPC）患者的谷睾酮水平和结局：PROTECH研究

ANNALS OF ONCOLOGY

IF65.4

2024-12-010

PRE

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial

ANNALS OF ONCOLOGY

IF65.4

2024-10-013

OAAI

Efficacy and safety of second-line therapy by S-1 combined with sintilimab and anlotinib in pancreatic cancer patients with liver metastasis: a single-arm, phase II clinical trial

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-02-013

OAAI

PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with BRPC/LAPC A biomolecular exploratory, phase II trial

CELL REPORTS MEDICINE

IF10.6

2023-03-0113

OAAI

Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer

预测晚期胰腺癌患者对PD-1抑制剂反应的生物标志物

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2023-02-2114

OAAI

Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2022-11-222

OAAI

MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1

CELL DEATH & DISEASE

IF9.6

2022-11-0423

OAAI

RETRACTED: Extracellular Vesicles Derived from Lung Cancer Cells Induce Transformation of Normal Fibroblasts into Lung Cancer-Associated Fibroblasts and Promote Metastasis of Lung Cancer by Delivering lncRNA HOTAIR (Retracted Article)

STEM CELLS INTERNATIONAL

IF3.3

2022-10-119

Study protocol for a prospective, open-label, single-arm, phase II study on the combination of tislelizumab, nab-paclitaxel, gemcitabine, and concurrent radiotherapy as the induction therapy for patients with locally advanced and borderline resectable pancreatic cancer

FRONTIERS IN ONCOLOGY

IF3.3

2022-08-183

OAAI

LncRNA A2M-AS1 Promotes Ferroptosis in Pancreatic Cancer via Interacting With PCBP3

LncRNA A2M-AS1通过与PCBP3相互作用促进胰腺癌的铁死亡

MOLECULAR CANCER RESEARCH

IF4.7

2022-08-0320

Case Report: Pathologic Complete Response to Induction Therapy in a Patient With Potentially Resectable Pancreatic Cancer

病例报告: 潜在可切除的胰腺癌患者对诱导治疗的病理完全反应

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-063

OAAI

Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy

晚期胰腺癌的分子景观和预后生物标志物分析以及AG化疗疗效的预测因素

FRONTIERS IN ONCOLOGY

IF3.3

2022-05-186

OAAI

Construction of recombinant adenovirus vector with connexin 43 gene

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

IF3.4

2022-03-032

PREAI

Xin Qiu

个人简介

教育背景

工作经历

荣誉奖项

研究方向